ESSA Pharma Inc. Investigation Ongoing: Contact Levi & Korsinsky About Potential Securities Fraud Allegations - EPIX
Portfolio Pulse from
Levi & Korsinsky has initiated an investigation into ESSA Pharma Inc. for potential securities fraud. This follows ESSA's announcement of ending its Phase 2 trial for a prostate cancer treatment.
November 12, 2024 | 10:30 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
ESSA Pharma Inc. is under investigation by Levi & Korsinsky for potential securities fraud after halting a Phase 2 trial for a prostate cancer treatment.
The investigation into potential securities fraud is likely to negatively impact investor confidence in ESSA Pharma Inc., leading to a potential decline in stock price. The halting of a Phase 2 trial is a significant event that could affect the company's future prospects and investor sentiment.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100